Tongshuo Zhang

Mr. Tongshuo Zhang

Department of Laboratory and Pathology, Jiangsu Provincial Corps Hospital of Chinese Peoples Armed Police Force, City of Calamba, Laguna, Philippines
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
SXShiwen Xu
Shiwen Xu
CYChunyan Yu
Chunyan Yu
XMXiaoxia Ma
Xiaoxia Ma
YLYan Li
Yan Li
YSYangyang Shen
Yangyang Shen
YWYue Wang
Yue Wang

14 December 2015 in SpringerPlus
Verified
Journal Article
Open access
PDF file
Tongshuo ZhangTongshuo Zhang
Tongshuo Zhang
HQHua-Lei Qin
Hua-Lei Qin
TWTong Wang
Tong Wang
HLHai-Tao Li
Hai-Tao Li
SXShihai Xia
Shihai Xia
XXXiao-Hui Xiang
Xiao-Hui Xiang
With the globally increasing prevalence, nonalcoholic fatty liver disease (NAFLD) becomes the predominant cause of chronic liver disease. A global look at the publication trends and the research hotspots of NAFLD are urgently needed to assess the situation of NAFLD research. The global scientific research in the Science Citation Index-Expanded covered articles relevant to NAFLD was retrieved and its bibliometric parameters and research hotspots of NAFLD were systematically evaluated. To sum up, 6356 articles were published in 994 different journals covering 93 SCI subject categories during 1986–2013, in which English was the most predominant language used. Starting from the late 1980s, the publication on NAFLD grew slowly and entered into a highly developing period in the 21st century, especially in the last decade. Besides hepatic steatosis, metabolic syndrome and its combination of symptoms such as obesity, insulin resistance are listed as the top frequent keywords. Bibliometric results suggest that the obviously rapid growth of the articles in recent years appears to be associated with the accelerating incidence of NAFLD and its cofactors such as metabolic syndrome. In addition, epidemiology focusing on comparing different regions and population is attracting ever-growing attention. Meantime, pathology plays an important role in NAFLD research.

1 January 2023 in Analytical Cellular Pathology
Verified
Journal Article
Open access
PDF file
Tongshuo ZhangTongshuo Zhang
Tongshuo Zhang
JYJing Yang
Jing Yang
YSYang Sun
Yang Sun
JSJiangnan Song
Jiangnan Song
DGDandan Gao
Dandan Gao
YLYanqiu Li
Yanqiu Li
Extensive peritoneal spread and capacity for distant metastasis account for the majority of mortality from epithelial ovarian cancer (EOC). Accumulating evidence shows that interleukin‐6 (IL‐6) promotes tumor invasion and migration in EOC, although the molecular mechanisms remain to be fully elucidated. Meanwhile, the hypoxic microenvironment has been recognized to cause metastasis by triggering epithelial–mesenchymal transition (EMT) in several types of cancers. Here, we studied the synergy between IL‐6 and hypoxia in inducing EMT in two EOC cell lines, A2780 cells and SKOV3 cells. Exogenous recombination of IL‐6 and autocrine production of IL‐6 regulated by plasmids both induced EMT phenotype in EOC cells characterized by downregulated E‐cadherin as well as upregulated expression of vimentin and EMT‐related transcription factors. The combined effects of IL‐6 and hypoxia were more significant than those of either one treatment on EMT. Suppression of hypoxia‐inducible factor‐1α (HIF‐1α) before IL‐6 treatment inhibited the EMT phenotype and invasion ability of EOC cells, indicating that HIF‐1α occupies a key position in the regulatory pathway of EMT associated with IL‐6. EMT score was found positively correlated with mRNA levels of IL‐6, signal transducer and activator of transcription 3 (STAT3), and HIF‐1α, respectively, in 489 ovarian samples from The Cancer Genome Atlas dataset. Next, blockade of the abovementioned molecules by chemical inhibitors reversed the alteration in the protein levels of EMT markers induced by either exogenous or endogenous IL‐6. These findings indicate a positive feedback loop between IL‐6 and HIF‐1α, and induce and maintain EMT phenotype through STAT3 signaling, which might provide a novel rationale for prognostic prediction and therapeutic targets in EOC.

17 December 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
XNXuegang Niu
Xuegang Niu
JSJiangnan Sun
Jiangnan Sun
LMLingyin Meng
Lingyin Meng
TFTao Fang
Tao Fang
Tongshuo ZhangTongshuo Zhang
Tongshuo Zhang
HLHuanming Li
Huanming Li
Accumulating studies have confirmed the crucial role of long non-coding RNAs (ncRNAs) as favorable biomarkers for cancer diagnosis, therapy, and prognosis prediction. In our recent study, we established a robust model which is based on multi-gene signature to predict the therapeutic efficacy and prognosis in glioblastoma (GBM), based on Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA) databases. lncRNA-seq data of GBM from TCGA and CGGA datasets were used to identify differentially expressed genes (DEGs) compared to normal brain tissues. The DEGs were then used for survival analysis by univariate and multivariate COX regression. Then we established a risk score model, depending on the gene signature of multiple survival-associated DEGs. Subsequently, Kaplan-Meier analysis was used for estimating the prognostic and predictive role of the model. Gene set enrichment analysis (GSEA) was applied to investigate the potential pathways associated to high-risk score by the R package “cluster profile” and Wiki-pathway. And five survival associated lncRNAs of GBM were identified: LNC01545, WDR11-AS1, NDUFA6-DT, FRY-AS1, TBX5-AS1. Then the risk score model was established and shows a desirable function for predicting overall survival (OS) in the GBM patients, which means the high-risk score significantly correlated with lower OS both in TCGA and CGGA cohort. GSEA showed that the high-risk score was enriched with PI3K-Akt, VEGFA-VEGFR2, TGF-beta, Notch, T-Cell pathways. Collectively, the five-lncRNAs signature-derived risk score presented satisfactory efficacies in predicting the therapeutic efficacy and prognosis in GBM and will be significant for guiding therapeutic strategies and research direction for GBM.

2 November 2021 in Bioactive Materials
Verified
Journal Article
Open access
SXShanshan Xu
Shanshan Xu
CWChenhong Wang
Chenhong Wang
RMRuoqing Mao
Ruoqing Mao
XLXiaoyu Liang
Xiaoyu Liang
HWHeran Wang
Heran Wang
LYLiu Ying
Liu Ying
Peritoneal adhesion is the most common adverse effect following abdominal surgery or inflammation. The occurrence in clinical trials has been successfully reduced using barriers. However, the shortcomings of frequently used adhesion barriers, such as rapid degradation rate of gel barrier and inadequate operation ability of solid barrier, cannot be ignored. In this study, a fibrous membrane with an ECM-like structure was prepared. The adhesion properties were reduced significantly by changing the surface structure. The fibrous membrane caused less inflammatory response and much less peripheral adhesion and intestinal obstruction compared to the casting film and the commercial film with smooth surface, though with the same components. Because of the auto-soft bionic structure and similarity in the mechanical modulus of the tissues, the fibrous membrane was more flexible when it adhered to the tissues, showed excellent effectiveness and biocompatibility. In addition to the rat and miniature pig models, a randomized, placebo-controlled, and multicenter clinical pilot study with 150 patients confirmed that because of its flexibility, biodegradability, and similarity to mechanical modulus and structure with tissues involved, the fibrous membrane served as a favorable implant for preventing post-operation adhesion.

1 January 2016 in World Journal of Hepatology
Verified
Journal Article
Open access
Tongshuo ZhangTongshuo Zhang
Tongshuo Zhang
HQHua-Lei Qin
Hua-Lei Qin
TWTong Wang
Tong Wang
HLHai-Tao Li
Hai-Tao Li
HLHai Li
Hai Li
XXXiao-Hui Xiang
Xiao-Hui Xiang
Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research